病理科

　　北京大學(xué)第三醫(yī)院病理科是國家臨床重點(diǎn)?？?，是全國大型的疑難病例病理診斷中心之一。病理科依托于歷史悠久的北京大學(xué)醫(yī)學(xué)部病理系，在幾代病理學(xué)工作者的辛勤耕耘和努力開拓下，發(fā)展成為教學(xué)、科研、臨床相結(jié)合的優(yōu)勢(shì)學(xué)科。經(jīng)多年醫(yī)療實(shí)踐積淀，科室不斷開拓創(chuàng)新以適應(yīng)日益增長(zhǎng)的?？苹t(yī)療服務(wù)需求。目前形成了包括泌尿病理、血液病理、神經(jīng)病理、消化病理、呼吸病理、婦科病理、乳腺病理、皮科病理、內(nèi)分泌病理、軟組織與骨關(guān)節(jié)病理、細(xì)胞學(xué)、解剖病理和分子病理等涵蓋人體多個(gè)系統(tǒng)的十三個(gè)病理亞?？?。病理科于2004 年，就成為第一批國家級(jí)繼續(xù)教育基地；2006 年，首批入選北京市住院醫(yī)師規(guī)范化培訓(xùn)臨床病理?？苹?；2010 年底，首批入選“國家臨床重點(diǎn)病理?？平ㄔO(shè)項(xiàng)目”。 　　病理科擁有一支梯隊(duì)合理的專業(yè)醫(yī)師隊(duì)伍，一批國內(nèi)知名病理學(xué)專家。同時(shí)，病理科也擁有一個(gè)專業(yè)的醫(yī)技團(tuán)隊(duì)，涵蓋常規(guī)病理平臺(tái)、免疫組化平臺(tái)、特殊染色平臺(tái)、超微病理平臺(tái)、針吸細(xì)胞學(xué)平臺(tái)和分子病理學(xué)平臺(tái)等，有力的支持了臨床病理診斷、教學(xué)和科研工作。病理科下屬的分子病理實(shí)驗(yàn)室，是我國第一批獲得衛(wèi)生部臨檢中心認(rèn)證的臨床基因擴(kuò)增檢驗(yàn)實(shí)驗(yàn)室。同時(shí)也是國家衛(wèi)健委病理質(zhì)控評(píng)價(jià)中心（PQCC）示范實(shí)驗(yàn)室和北京市重點(diǎn)實(shí)驗(yàn)室。 　　目前，科室已發(fā)展為年組織學(xué)樣本量 9 萬例、細(xì)胞學(xué) 6.5 萬例、尸體解剖 50例、電鏡 6000 例、會(huì)診 7000 例、分子病理檢測(cè) 6000 例、集臨床、教學(xué)和科研為一體、從大體、光鏡、電鏡觀察到免疫組化、遺傳學(xué)檢測(cè)的系統(tǒng)化、標(biāo)準(zhǔn)化、數(shù)字化和信息化集成，臨床病理工作水平位于全國領(lǐng)先的綜合學(xué)科。 　　The Department of Pathology of Peking University Third Hospital (Dpt. Path.) is a national key clinical specialty and is one of the large-scale pathological consultation center in China. The Dpt. Path. relies on the Department of Pathology of Peking University Health Science Center. Through the hard working of several generations of pathologists, it has developed into a superior discipline with a combination of teaching, scientific research and clinical service, After years of accumulation of medical practice, the Dpt. Path. continue to innovate to meet the growing demand for specialized medical services. At present, it has formed a series of subspecialties consisting of urological pathology, hematopoietic pathology, neuropathology, gastrointestinal pathology, lung pathology, gynecological pathology, breast pathology, dermatology pathology, endocrine pathology, soft tissue-bone-joint pathology, cytology, anatomical pathology and molecular pathology. The Dpt. Path. became one of the first approved bases for national continuing education in 2004; in 2006, it was pioneered to be the standardized training base forclinical pathology residency in 2010, it was granted as one of the "National Key Clinical Pathology Specialty Construction Project". 　　The Dpt. Path. has a team of professional pathologists with reasonable echelon construction,, and producing a group of well-known domestic experts. The Dpt. Path. also has a professional medical technologists team, covering conventional pathology platform, immunohistochemistry platform, special staining platform, ultrastructuralpathology platform, fine needle aspiration cytology platform and molecular pathology platform, etc., which strongly supports clinical pathological diagnosis, teaching and scientific research. The Molecular Pathology Laboratory affiliated the Dpt. Path. is the first batch of clinical gene amplification testing laboratories certified by the National Center of Ministry of Health for Clinical Laboratories. Meanwhile, this lab is also a demonstration laboratory of the National Pathology Quality Control Center (PQCC) and a key laboratory in Beijing. 　　At present, the Dpt. Path. has an annual histological samples of 90,000 cases, cytology 65,000 cases, autopsy 50 cases, electron microscopy 6,000 cases, consultation 7000 cases and molecular pathology examination 6000 cases. Integrating clinical, teaching and scientific research, the Dpt. Path. is a nationally leading comprehensive department for clinical pathology, from general, light microscope and electron microscope observations to the systematic, standardized, digital and information integration of immunohistochemistry and genetic testing.